A61K 41/0047
Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
Official title: {Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent}
A61K41/0047 (Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent) appears on 155 US grants and 295 published applications in this corpus.
Search patents in A61K- Granted patents
- 155
- Published applications
- 295
- Assignees
- 177
- Inventors
- 520
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 4 |
| 2002 | 1 | 4 |
| 2003 | 4 | 15 |
| 2004 | 4 | 7 |
| 2005 | 2 | 6 |
| 2006 | 0 | 2 |
| 2007 | 5 | 6 |
| 2008 | 1 | 4 |
| 2009 | 1 | 3 |
| 2010 | 1 | 7 |
| 2011 | 5 | 6 |
| 2012 | 3 | 7 |
| 2013 | 0 | 6 |
| 2014 | 9 | 17 |
| 2015 | 4 | 15 |
| 2016 | 3 | 15 |
| 2017 | 12 | 14 |
| 2018 | 10 | 10 |
| 2019 | 8 | 17 |
| 2020 | 9 | 18 |
| 2021 | 8 | 23 |
| 2022 | 4 | 14 |
| 2023 | 9 | 23 |
| 2024 | 5 | 20 |
| 2025 | 9 | 16 |
| 2026 | 8 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Optimized synthetic consensus immunogenic compositions targeting fibroblast activation protein4 Aug 2026US 12,697,298 B2The Trustees of the University of Pennsylvania
- Drug transdermal delivery system28 Jul 2026US 12,691,175 B2Xiamen University
- Topical lipolysis composition and methods5 May 2026US 12,616,651 B2Lipodissolve Therapeutics Inc.
- Stem cell-nano drug delivery system complex, use thereof and method for preparing the same21 Apr 2026US 12,605,460 B2Gachon University of Industry-Academic Cooperation Foundation
- Electroporation-targeted delivery of ribosome inactivating protein gelonin into mammalian cells10 Feb 2026US 12,544,420 B2Old Dominion University Research Foundation
- Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid delivery1 Oct 2026US 2026/0295083 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Substantially Monodisperse Ultrasound Responsive Nanobubble Compositions and Methods of Production and Use Thereof13 Aug 2026US 2026/0232849 A1University of Central Florida Research Foundation, Inc.
- Method to enhance transport across the blood-brain barrier via vasodilation triggered by vibroacoustic therapy and/or other stacked sensory inputs allowing for synergistic benefits with pharmacological treatments for neurological and circulatory diseases6 Aug 2026US 2026/0224874 A1Kuranda Services LLC
- Method to enhance transport across the blood-brain barriervia vasodilation triggered by vibroacoustic therapy and/orother stacked sensory inputs allowing for synergisticbenefits with pharmacological treatments for neurologicaland circulatory diseases6 Aug 2026US 2026/0224875 A1Kuranda Services LLC
- Methods and compositions for improved delivery via ultrasound23 Jul 2026US 2026/0207786 A1SonoThera, Inc.
Most cited
By later US patents
- Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)1,242US 4,787,888 AUniversity of Connecticut · 1988
- Microporation of human skin for monitoring the concentration of an analyte944US 5,885,211 AAltea Technologies, Inc. · 1999
- Transdermal delivery of encapsulated drugs775US 5,814,599 AMassachusetts Insitiute of Technology · 1998
- Microporation of human skin for drug delivery and monitoring applications699US 6,142,939 AAltea Technologies, Inc. · 2000
- Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers506US 5,458,140 ANon-Invasive Monitoring Company (NIMCO) · 1995